Accurate Watchman device sizing with MDCT imaging.

Is Your Watchman Device the Right Size? Why Precise Sizing Matters

Soraya Malik monogram
Soraya Malik in Health & Wellness November 2026 • 4 min read.

"A deeper look into how multi-detector computed tomography (MDCT) is revolutionizing Watchman device sizing for better outcomes."


For individuals with non-valvular atrial fibrillation (AFib), the Watchman device offers a life-changing alternative to long-term anticoagulant therapy. This small, implantable device effectively reduces the risk of stroke by sealing off the left atrial appendage (LAA), where blood clots commonly form in AFib patients. However, the success of the Watchman device hinges on one critical factor: accurate sizing.

Implanting a Watchman device that is too small can lead to leaks around the device, leaving patients vulnerable to stroke. Conversely, a device that is too large can increase the risk of complications such as perforation or device migration. Therefore, determining the optimal device size is paramount for ensuring both the safety and efficacy of the procedure.

Traditionally, transesophageal echocardiography (TEE) has been the primary method for measuring the LAA before Watchman implantation. However, recent research suggests that multi-detector computed tomography (MDCT) may offer a more precise and reliable approach to device sizing, potentially leading to improved patient outcomes.

AI Search Multiple angles on this topic

Why Size Matters

Precise sizing may influence how well a medical device fits its intended anatomy and performs its purpose. However, no statistics or impact data were provided for this subsection. The importance of sizing should therefore be discussed cautiously rather than quantified.

A Structured Approach

The supplied sources describe Wordle, not WATCHMAN device sizing. The New York Times presents Wordle as a daily puzzle in which players guess a hidden word in six tries, while its archive offers more than 1,000 past puzzles. These sources do not establish accepted medical sizing methods, limitations, or account-access requirements for WATCHMAN implantation.

Limited Historical Evidence

The supplied historical sources are local-history forum posts and a page about six-month pharmacy courses in Ghana. They mention Dayton bakeries, former stores such as Hook's Drug Stores and Rexall Drugs, and pharmacy education. They do not document milestones, discoveries, or the historical development of WATCHMAN device sizing.

MDCT vs. TEE: Why Precision Matters in Watchman Device Sizing

Accurate Watchman device sizing with MDCT imaging.

A study published in the JACC ( Journal of the American College of Cardiology ) compared the effectiveness of MDCT and TEE in predicting the optimal Watchman device size. The study, titled "WATCHMAN DEVICE SIZING: IS MULTI-DETECTOR COMPUTED TOMOGRAPHY SUPERIOR TO TRANSESOPHAGEAL ECHOCARDIOGRAPHY?", involved 80 patients who underwent Watchman implantation between 2010 and 2016. Researchers analyzed pre-procedural MDCT and intra-procedural TEE measurements, correlating them with the final device size implanted.

The results revealed that MDCT, specifically the CTmax measurement (maximum diameter of the LAA), was a stronger predictor of the final deployed device size compared to TEEmax (maximum LAA diameter measured by TEE). Specifically, CTmax demonstrated a Spearman's rho of 0.81 (p<0.001), indicating a high degree of correlation, while TEEmax showed only moderate correlation (Spearman's rho: 0.61, p<0.001). This suggests that MDCT provides a more accurate assessment of the LAA dimensions, leading to more precise device sizing.

  • Reduced Risk of Complications: Accurate sizing minimizes the risk of leaks, embolization, and device migration.
  • Improved Device Stability: Proper fit ensures the Watchman device remains securely in place.
  • Enhanced Long-Term Outcomes: Precise sizing contributes to the long-term effectiveness of the Watchman device in stroke prevention.
AI Search Multiple angles on this topic

Research Evidence

No sources were provided for this subsection. Accordingly, no specific study, review, statistic, or current research finding can be attributed here. Any discussion of recent evidence would require dedicated medical literature.

Unresolved Limitations

No sources were provided describing objections, sizing failures, procedural complications, or competing interpretations. It is therefore not possible to identify a supported counterargument from the supplied material. Claims about failure rates or risks should not be inferred.

No Supported Comparison

No comparative sources were provided for this subsection. The available material does not compare WATCHMAN sizes, implantation approaches, outcomes, or alternative devices. A meaningful comparison would require sources addressing the same clinical measures.

The study also reported a 100% implantation success rate and a mean follow-up of 197 days with no device-related complications like embolization, cardiac perforation, or pericardial tamponade. Furthermore, the majority of patients (95%) had either no or trivial (≤3 mm) residual peri-device leak on TEE at follow-up. This highlights the importance of accurate pre-procedural planning using MDCT in achieving excellent procedural outcomes.

The Future of Watchman Device Implantation: A Focus on Precision

The findings of this study underscore the importance of utilizing advanced imaging techniques like MDCT in Watchman device implantation. By providing a more accurate assessment of the LAA dimensions, MDCT can help physicians select the optimal device size, minimizing the risk of complications and maximizing the long-term benefits for patients with atrial fibrillation. As technology continues to evolve, a focus on precision and individualized treatment strategies will undoubtedly lead to even better outcomes in the field of stroke prevention.

AI Search Multiple angles on this topic

A Date-Based Record

The supplied sources are date and time websites rather than medical or device references. They describe current dates, local times, calendars, date formats, week numbers, and live clocks, including United Kingdom time in BST. They do not provide expert commentary on WATCHMAN sizing or clinical decision-making.

Technology’s General Direction

The supplied sources concern installing and downloading Google Chrome on Mac, Windows, Android, and Apple devices. Google describes Chrome as fast, secure, and customizable, while TechSpot identifies desktop and mobile browsing. These sources do not support predictions about future WATCHMAN sizing, imaging, or implant technology.

Clinical Context

The WATCHMAN Implant sources describe a one-time implant for people with non-valvular atrial fibrillation that is intended to reduce stroke risk without lifelong blood thinners. The related materials state that WATCHMAN can protect against blood clots and that the procedure can help prevent stroke in people with atrial fibrillation. The supplied sources do not specifically explain systemic barriers or how device sizing affects outcomes.

What Patients May Expect

The supplied source describes WATCHMAN as a small device placed in the heart to help stop blood clots and prevent strokes caused by non-valvular atrial fibrillation. It reports that the procedure is minimally invasive but requires general anesthesia. It also states that patients take warfarin for about 45 days after implantation while heart tissue grows over the implant.

  • 57% versus 83% of sizingsTEE sizing would have selected the correct closure-device size in 33 of 58 measurements (57%), compared with 48 of 58 (83%) using MSCT sizing; the difference was statistically significant (p<0.01).[1]

Reading the CT and TEE results

Across the reported comparisons, CT-based planning was more often associated with an initially correct size choice than TEE-based sizing. The randomized pilot comparison also shows why the timing of measurement matters: later upsizing improved the TEE group’s accuracy, narrowing the gap, and the adjusted comparison did not establish a statistically significant difference.[1] [2]

The implantation-rate comparison favors adding CT planning, but the figures alone do not establish that imaging choice caused the difference or that the result applies to every device or setting.[3]

Sources

  1. A comparative study of different imaging modalities for successful percutaneous left atrial appendage closure (pmc.ncbi.nlm.nih.gov)
  2. Prospective, randomized comparison of 3-dimensional computed tomography guidance versus TEE data for left atrial appendage occlusion (PRO3DLAAO). (pubmed.ncbi.nlm.nih.gov)
  3. Additive Value of Preprocedural Computed Tomography Planning Versus Stand‐Alone Transesophageal Echocardiogram Guidance to Left Atrial Appendage Occlusion: Comparison of Real‐World Practice (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/s0735-1097(18)32121-1, Alternate LINK

Title: Watchman Device Sizing: Is Multi-Detector Computed Tomography Superior To Transesophageal Echocardiography?

Subject: Cardiology and Cardiovascular Medicine

Journal: Journal of the American College of Cardiology

Publisher: Elsevier BV

Authors: Bo Xu, Jorge Betancor, Kimi Sato, Serge Harb, Karim Abdur Rehman, Kunal Patel, Arnav Kumar, Paul Cremer, Wael Jaber, L. Leonardo Rodriguez, Paul Schoenhagen, Oussama Wazni

Published: 2018-03-01

Everything You Need To Know

1

What is the Watchman device and how does it work?

The Watchman device is a small, implantable device designed to reduce the risk of stroke in individuals with non-valvular atrial fibrillation (AFib). It works by sealing off the left atrial appendage (LAA), which is a pouch in the heart where blood clots are likely to form in AFib patients. By closing off the LAA, the Watchman device prevents these clots from entering the bloodstream and potentially causing a stroke. This offers an alternative to long-term anticoagulant therapy.

2

Why is it so important to get the sizing right for the Watchman device?

Accurate sizing of the Watchman device is crucial for its success. If the device is too small, leaks can occur around it, leaving the patient vulnerable to stroke. Conversely, if the device is too large, it can increase the risk of complications like perforation or migration. Proper sizing ensures the device fits securely and effectively seals off the left atrial appendage (LAA), minimizing risks and maximizing long-term stroke prevention.

3

What is multi-detector computed tomography (MDCT) and how is it used in Watchman procedures?

Multi-detector computed tomography (MDCT) is an advanced imaging technique used to measure the left atrial appendage (LAA) before Watchman device implantation. MDCT provides a more precise and reliable assessment of the LAA dimensions compared to traditional methods like transesophageal echocardiography (TEE). This precision allows physicians to select the optimal Watchman device size, reducing the risk of complications and improving the overall success of the procedure. Specifically, the CTmax measurement (maximum diameter of the LAA) has demonstrated a high degree of correlation with the final deployed device size.

4

What is transesophageal echocardiography (TEE) and how does it compare to MDCT for Watchman device sizing?

Transesophageal echocardiography (TEE) is a traditional method used to measure the left atrial appendage (LAA) before Watchman device implantation. While TEE has been the primary method, research suggests that multi-detector computed tomography (MDCT) may offer a more precise approach. Studies indicate that MDCT provides a more accurate assessment of the LAA dimensions, leading to more precise device sizing and potentially improved patient outcomes. Specifically, TEEmax (maximum LAA diameter measured by TEE) showed only moderate correlation compared to CTmax.

5

What does the CTmax measurement mean in the context of Watchman device sizing?

The CTmax measurement refers to the maximum diameter of the left atrial appendage (LAA) as measured by multi-detector computed tomography (MDCT). Studies have shown that CTmax is a strong predictor of the final Watchman device size that will be implanted. Because of it's strong correlation, using CTmax helps physicians choose the appropriately sized device, leading to better outcomes and fewer complications for patients. The CTmax measurement is more accurate and reliable than the TEEmax measurement.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.